Researcher
Kathleen Lambein
- Keywords:Medicine
- Disciplines:Morphological sciences, Oncology, Orthopaedics, Surgery, Nursing
Affiliations
- Surgical Oncology (Division)
Member
From15 Mar 2015 → Today
Projects
1 - 1 of 1
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 24
- Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast(2022)
Authors: Kathleen Lambein
Pages: 367 - 375Number of pages: 9 - Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer(2021)
Authors: Hanne Vos, Kathleen Lambein, François Richard, Kevin Punie, Hans Wildiers, Lieze Berben, Annouschka Laenen, Giuseppe Floris, Christine Desmedt, Ann Smeets
Number of pages: 5 - Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study(2021)
Authors: Giuseppe Floris, Kathleen Lambein, Anne-Sophie Van Rompuy
Pages: 2130 - 2140Number of pages: 11 - A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer(2021)
Authors: Ayse Bassez, Hanne Vos, Laurien Van Dyck, Giuseppe Floris, Ingrid Arijs, Christine Desmedt, Marlies Vanden Bempt, Ines Nevelsteen, Kathleen Lambein, Kevin Punie, et al.
Pages: 820 - +Number of pages: 40 - Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study(2020)
Authors: Giuseppe Floris, Kathleen Lambein, Anne-Sophie Van Rompuy
Pages: 354 - 366Number of pages: 13 - Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.(2019)
Authors: Kathleen Lambein, Ann Smeets, Laurence Slembrouck, Patrick Neven, Ines Nevelsteen, Caroline Weltens, Erik Van Limbergen, Marie-Rose Christiaens, Chantal Van Ongeval, Hans Wildiers, et al.
Pages: 550 - 559Number of pages: 10 - HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?(2019)
Authors: Kathleen Lambein, Louis Libbrecht, Christine Galant, Mieke R Van Bockstal
Pages: 666 - 668Number of pages: 3 - Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance(2018)
Authors: Marcella Baldewijns, Giuseppe Floris, Kathleen Lambein, Anne-Sophie Van Rompuy
Pages: 923 - 932Number of pages: 10 - Collagen Alignment and Recurrence of DCIS-Letter(2018)
Authors: Louis Libbrecht, Kathleen Lambein, Mieke Van Bockstal, Hannelore Denys
Pages: 613 - 613Number of pages: 1 - A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer(2018)
Authors: Giuseppe Floris, Kathleen Lambein, Louis Libbrecht
Pages: 52 - 55Number of pages: 4